NCT01247675View on ClinicalTrials.gov

A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Adult Growth Hormone Deficiency
Interventions
DRUG

ACP-001 (TransCon hGH)

s.c., weekly injection

DRUG

ACP-001 (TransCon hGH)

s.c., weekly injection

DRUG

ACP-001 (TransCon hGH)

s.c., weekly injection

DRUG

Omnitrope

s.c., daily injection

Trial Locations (4)

8000

Aarhus University Hospital, Aarhus

12203

Charité University Hospital Berlin, Berlin

16132

University Hospital Genova, Genova

17176

Karolinska University Hospital, Stockholm

Sponsors
All Listed Sponsors
lead

Ascendis Pharma A/S

INDUSTRY